{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:43:01Z","timestamp":1780519381155,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nbd.2025.107078","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T06:11:46Z","timestamp":1756707106000},"page":"107078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The predictive validity of pontine volume change in spinocerebellar ataxia type 1 (SCA1)"],"prefix":"10.1016","volume":"215","author":[{"given":"Teije H.","family":"van Prooije","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten C.J.","family":"Kapteijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack J.A.","family":"van Asten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel M.","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W.J.","family":"Scheenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart P.","family":"van de Warrenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.107078_bb0005","series-title":"Considerations for Discussion of a New Surrogate Endpoint(s) at a Type C PDUFA Meeting Reques","author":"(FDA), U.S.F.D.A","year":"2018"},{"key":"10.1016\/j.nbd.2025.107078_bb0010","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.nicl.2018.06.011","article-title":"Autosomal dominant cerebellar ataxias: imaging biomarkers with high effect sizes","volume":"19","author":"Adanyeguh","year":"2018","journal-title":"NeuroImage: Clin."},{"key":"10.1016\/j.nbd.2025.107078_bb0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/mds.30158","article-title":"Spinocerebellar Ataxia progression measured with the patient-reported outcome measure of Ataxia","volume":"40","author":"Burt","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107078_bb0020","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ana.26573","article-title":"Clinically meaningful magnetic resonance endpoints sensitive to Preataxic spinocerebellar Ataxia types 1 and 3","volume":"93","author":"Chandrasekaran","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.107078_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105311","article-title":"Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia","volume":"153","author":"Coarelli","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.nbd.2025.107078_bb0030","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/mdc3.12804","article-title":"Sensitivity of volumetric magnetic resonance imaging and magnetic resonance spectroscopy to progression of spinocerebellar Ataxia type 1","volume":"6","author":"Deelchand","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.nbd.2025.107078_bb0035","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.neuroimage.2004.07.016","article-title":"Sequence-independent segmentation of magnetic resonance images","volume":"23","author":"Fischl","year":"2004","journal-title":"Neuroimage"},{"issue":"Pt 8","key":"10.1016\/j.nbd.2025.107078_bb0040","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/brain\/awh201","article-title":"Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study","volume":"127","author":"Guerrini","year":"2004","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.nbd.2025.107078_bb0045","first-page":"136","volume":"11","year":"1996","journal-title":"Huntington Study Group. Mov Disord."},{"key":"10.1016\/j.nbd.2025.107078_bb0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuroimage.2015.02.065","article-title":"Bayesian segmentation of brainstem structures in MRI","volume":"113","author":"Iglesias","year":"2015","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.nbd.2025.107078_bb0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12311-012-0421-3","article-title":"Inventory of non-Ataxia signs (INAS): validation of a new clinical assessment instrument","volume":"12","author":"Jacobi","year":"2013","journal-title":"Cerebellum"},{"issue":"11","key":"10.1016\/j.nbd.2025.107078_bb0060","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","article-title":"Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study","volume":"14","author":"Jacobi","year":"2015","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2025.107078_bb0065","doi-asserted-by":"crossref","first-page":"fcaa184","DOI":"10.1093\/braincomms\/fcaa184","article-title":"Brainstem and striatal volume changes are detectable in under 1 year and predict motor decline in spinocerebellar ataxia type 1","volume":"2","author":"Koscik","year":"2020","journal-title":"Brain. Commun."},{"issue":"1","key":"10.1016\/j.nbd.2025.107078_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12311-021-01285-0","article-title":"Spinocerebellar Ataxia type 1: one-year longitudinal study to identify clinical and MRI measures of disease progression in patients and presymptomatic carriers","volume":"21","author":"Nigri","year":"2022","journal-title":"Cerebellum"},{"issue":"5","key":"10.1016\/j.nbd.2025.107078_bb0075","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1007\/s12311-024-01700-2","article-title":"Content validity of the modified functional scale for the assessment and rating of Ataxia (f-SARA) instrument in spinocerebellar Ataxia","volume":"23","author":"Potashman","year":"2024","journal-title":"Cerebellum"},{"issue":"5","key":"10.1016\/j.nbd.2025.107078_bb0080","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s12311-024-01707-9","article-title":"Psychometric validation of the modified functional scale for the assessment and rating of Ataxia (f-SARA) in patients with spinocerebellar Ataxia","volume":"23","author":"Potashman","year":"2024","journal-title":"Cerebellum"},{"issue":"Pt 3","key":"10.1016\/j.nbd.2025.107078_bb0085","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/brain\/aws369","article-title":"Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6","volume":"136","author":"Reetz","year":"2013","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nbd.2025.107078_bb0090","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.neuroimage.2012.02.084","article-title":"Within-subject template estimation for unbiased longitudinal image analysis","volume":"61","author":"Reuter","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbd.2025.107078_bb0095","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/mds.29934","article-title":"Sensitivity of advanced magnetic resonance imaging to progression over six months in early spinocerebellar Ataxia","volume":"39","author":"Rezende","year":"2024","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.nbd.2025.107078_bb0100","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","article-title":"Scale for the assessment and rating of ataxia: development of a new clinical scale","volume":"66","author":"Schmitz-H\u00fcbsch","year":"2006","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nbd.2025.107078_bb0105","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/01.wnl.0000324863.76290.19","article-title":"SCA functional index: a useful compound performance measure for spinocerebellar ataxia","volume":"71","author":"Schmitz-H\u00fcbsch","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nbd.2025.107078_bb0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuroimage.2009.07.027","article-title":"Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6","volume":"49","author":"Schulz","year":"2010","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/j.nbd.2025.107078_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-012-1000-x","article-title":"Brain pathology of spinocerebellar ataxias","volume":"124","author":"Seidel","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.107078_bb0120","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s12311-022-01424-1","article-title":"The S-factor, a new measure of disease severity in spinocerebellar Ataxia: findings and implications","volume":"22","author":"Selvadurai","year":"2023","journal-title":"Cerebellum"},{"issue":"7","key":"10.1016\/j.nbd.2025.107078_bb0125","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.WNL.0000156802.15466.79","article-title":"Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale","volume":"64","author":"Subramony","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nbd.2025.107078_bb0130","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jmedgenet-2013-102200","article-title":"Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6","volume":"51","author":"Tezenas du Montcel","year":"2014","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2025.107078_bb0135","series-title":"The Voice of the Patient: Living with Polyglutamine Spinocerebellar Ataxias (SCA) and Dentatorubal-Pallidoluysian Atrophy (DRPLA)","author":"Trace","year":"2021"},{"key":"10.1016\/j.nbd.2025.107078_bb0140","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/ana.27032","article-title":"Multimodal, longitudinal profiling of SCA1 identifies predictors of disease severity and progression","volume":"96","author":"van Prooije","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.107078_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102495","article-title":"Effects of tofersen treatment in patients with SOD1-ALS in a \"real-world\" setting - a 12-month multicenter cohort study from the German early access program","volume":"69","author":"Wiesenfarth","year":"2024","journal-title":"EClinicalMedicine"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:23:41Z","timestamp":1759299821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125002955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":29,"alternative-id":["S0969996125002955"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107078","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The predictive validity of pontine volume change in spinocerebellar ataxia type 1 (SCA1)","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107078"}}